Gender Differences in Patterns and Correlates of Continued Substance Use among Patients in Methadone Maintenance Treatment

References

• Back, S. E., Lawson, K. M., Singleton, L. M., & Brady, K. T. (2011). Characteristics and correlates of men and women with prescription opioid dependence. Addictive Behaviors, 36(8), 829–834. https://doi.org/10.1016/j.addbeh.2011.03.013
   PubMed Web of Science ®Google Scholar
• Bawor, M., Dennis, B. B., Bhalerao, A., Plater, C., Worster, A., Varenbut, M., Daiter, J., Marsh, D. C., Desai, D., Steiner, M., Anglin, R., Pare, G., Thabane, L., & Samaan, Z. (2015). Sex differences in outcomes of methadone maintenance treatment for opioid use disorder: A systematic review and meta-analysis. CMAJ Open, 3(3), E344–E351. https://doi.org/10.9778/cmajo.20140089
   PubMedGoogle Scholar
• Bawor, M., Dennis, B. B., Varenbut, M., Daiter, J., Marsh, D. C., Plater, C., Worster, A., Steiner, M., Anglin, R., Pare, G., Desai, D., Thabane, L., & Samaan, Z. (2015). Sex differences in substance use, health, and social functioning among opioid users receiving methadone treatment: A multicenter cohort study. Biology of Sex Differences, 6 (1), 21. https://doi.org/10.1186/s13293-015-0038-6
   PubMedGoogle Scholar
• Becker, J. B., & Hu, M. (2008). Sex differences in drug abuse. Frontiers in Neuroendocrinology, 29(1), 36–47. https://doi.org/10.1016/j.yfrne.2007.07.003
   PubMed Web of Science ®Google Scholar
• Brady, K. T., Back, S. E., & Greenfield, S. F. (Eds.). (2009). Women and addiction: A comprehensive handbook.The Guilford Press.
   Google Scholar
• Celeux, G., & Soromenho, G. (1996). An entropy criterion for assessing the number of clusters in a mixture model. Journal of Classification, 13(2), 195–212. https://doi.org/10.1007/BF01246098
   Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (2018). Evidence-Based Strategies for Preventing Opioid Overdose: What’s Working in the United States. Retrieved April 19, 2019, from https://www.cdc.gov/drugoverdose/pdf/pubs/2018-evidence-based-strategies.pdf
   Google Scholar
• Chen, K. W., Banducci, A. N., Guller, L., Macatee, R. J., Lavelle, A., Daughters, S.B., & Lejuez, C. W. W. (2011). An examination of psychiatric comorbidities as a function of gender and substance type within an inpatient substance use treatment program. Drug and Alcohol Dependence, 118(2-3), 92–99. https://doi.org/10.1016/j.drugalcdep.2011.03.003
   PubMed Web of Science ®Google Scholar
• Cleland, C. M., Lanza, S. T., Vasilenko, S. A., & Gwadz, M. (2017). Syndemic risk classes and substance use problems among adults in high-risk urban areas: A latent class analysis. Frontiers in Public Health, 5(September), 1–11. https://doi.org/10.3389/fpubh.2017.00237
   PubMedGoogle Scholar
• Collins, L. M., & Lanza, S. T. (2009). Latent class and latent transition analysis: With applications in the social, behavioral, and health sciences. Wiley.
   Google Scholar
• Compton, W. M., Gfroerer, J., Conway, K. P., & Finger, M. S. (2014). Unemployment and substance outcomes in the United States 2002-2010. Drug and Alcohol Dependence, 142, 350–353. https://doi.org/10.1016/j.drugalcdep.2014.06.012
   PubMed Web of Science ®Google Scholar
• Compton, W. M., & Volkow, N. D. (2006). Abuse of prescription drugs and the risk of addiction. Drug and Alcohol Dependence, 83, S4–S7. https://doi.org/10.1016/j.drugalcdep.2005.10.020
   PubMed Web of Science ®Google Scholar
• Davstad, I., Stenbacka, M., Leifman, A., Beck, O., Korkmaz, S., & Romelsjo, A. (2007). Patterns of illicit drug use and retention in a methadone program: A longitudinal study. Journal of Opioid Management, 3(1), 27.
   PubMedGoogle Scholar
• de Souza, J., Villar Luis, M. A., Ventura, C. A., Barbosa, S. P., & dos Santos, C. B. (2016). Perception of social support: A comparative study between men with and without substance-related disorders. Journal of Substance Use, 21(1), 92–97. https://doi.org/10.3109/14659891.2014.966343
   Web of Science ®Google Scholar
• Edens, E. L., Mares, A. S., & Rosenheck, R. A. (2011). Chronically homeless women report high rates of substance use problems equivalent to chronically homeless men. Women’s Health Issues : official Publication of the Jacobs Institute of Women’s Health, 21(5), 383–389. https://doi.org/10.1016/j.whi.2011.03.004
   PubMed Web of Science ®Google Scholar
• Ehlers, C. L., Gizer, I. R., Vieten, C., Gilder, D. A., Stouffer, G. M., Lau, P., & Wilhelmsen, K. C. (2010). Cannabis dependence in the San Francisco Family Study: Age of onset of use, DSM-IV symptoms, withdrawal, and heritability. Addictive Behaviors, 35(2), 102–110. https://doi.org/10.1016/j.addbeh.2009.09.009
   PubMed Web of Science ®Google Scholar
• Fazel, S., Khosla, V., Doll, H., & Geddes, J. (2008). The prevalence of mental disorders among the homeless in western countries: Systematic review and meta-regression analysis. PLoS Medicine, 5(12), e225. https://doi.org/10.1371/journal.pmed.0050225
   PubMed Web of Science ®Google Scholar
• Fei, J. T. B., Yee, A., Habil, M. H. & Bin, (2016). Psychiatric comorbidity among patients on methadone maintenance therapy and its influence on quality of life. The American Journal on Addictions, 25(1), 49–55.
   PubMed Web of Science ®Google Scholar
• Florence, C. S., Zhou, C., Luo, F., & Xu, L. (2016). The economic burden of prescription opioid overdose, abuse, and dependence in the United States, 2013. Medical Care, 54(10), 901–906. https://doi.org/10.1097/MLR.0000000000000625
   PubMed Web of Science ®Google Scholar
• Glenn, M. C., Sohler, N. L., Starrels, J. L., Maradiaga, J., Jost, J. J., Arnsten, J.H., & Cunningham, C.O. (2016). Characteristics of methadone maintenance treatment patients prescribed opioid analgesics. Substance Abuse, 37(3), 387–391. https://doi.org/10.1080/08897077.2015.1135225
   PubMed Web of Science ®Google Scholar
• Goodman, L. A. (1974). Exploratory latent structure analysis using both identifiable and unidentifiable models. Biometrika, 61(2), 215–231. https://doi.org/10.1093/biomet/61.2.215
   Web of Science ®Google Scholar
• Gregory Hobelmann, J., & Clark, M. R. (2016). Benzodiazepines, ­alcohol, and stimulant use in combination with opioid use. In P. S. Staats & S.M. Silverman (Eds.), Controlled substance management in chronic pain: A balanced approach (pp. 75–86). Springer International Publishing.
   Google Scholar
• Gudicha, D. W., Tekle, F. B., & Vermunt, J. K. (2016). Power and sample size computation for wald tests in latent class models. Journal of Classification, 33(1), 30–51. https://doi.org/10.1007/s00357-016-9199-1
   Web of Science ®Google Scholar
• Hasin, D. S., & Grant, B. F. (2015). The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: Review and summary of findings. Social Psychiatry and Psychiatric Epidemiology, 50(11), 1609–1640. https://doi.org/10.1007/s00127-015-1088-0
   PubMed Web of Science ®Google Scholar
• Hassan, A. N., & Le Foll, B. (2019). Polydrug use disorders in individuals with opioid use disorder. Drug and Alcohol Dependence, 198, 28–33. https://doi.org/10.1016/j.drugalcdep.2019.01.031
   PubMed Web of Science ®Google Scholar
• Huang, B., Dawson, D. A., Stinson, F. S., Hasin, D. S., Ruan, W. J., Saha, T. D., Smith, S. M., Goldstein, R. B., & Grant, B. F. (2006). Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: Results of the National Epidemiologic Survey on Alcohol and Related Conditions. The Journal of Clinical Psychiatry, 67(7), 1062–1073. https://doi.org/10.4088/jcp.v67n0708
   PubMed Web of Science ®Google Scholar
• Ibabe, I., Stein, J. A., Nyamathi, A., & Bentler, P. M. (2014). Predictors of substance abuse treatment participation among homeless adults. Journal of Substance Abuse Treatment, 46(3), 374–381. https://doi.org/10.1016/j.jsat.2013.10.008
   PubMed Web of Science ®Google Scholar
• Jimenez-Treviño, L., Saiz, P. A., García-Portilla, M. P., Díaz-Mesa, E. M., Sánchez-Lasheras, F., Burón, P., Casares, M. J., Marina, P., Gutiérrez, E., & Bobes, J. (2011). A 25-year follow-up of patients admitted to methadone treatment for the first time: Mortality and gender differences. Addictive Behaviors, 36(12), 1184–1190. https://doi.org/10.1016/j.addbeh.2011.07.019
   PubMed Web of Science ®Google Scholar
• John, W. S., Zhu, H., Mannelli, P., Schwartz, R. P., Subramaniam, G. A., & Wu, L.-T. (2018). Prevalence, patterns, and correlates of multiple substance use disorders among adult primary care patients. Drug and Alcohol Dependence, 187, 79–87. https://doi.org/10.1016/j.drugalcdep.2018.01.035
   PubMed Web of Science ®Google Scholar
• Jones, J. D., Mogali, S., & Comer, S. D. (2012). Polydrug abuse: A review of opioid and benzodiazepine combination use. Drug and Alcohol Dependence, 125(1-2), 8–18. https://doi.org/10.1016/j.drugalcdep.2012.07.004
   PubMed Web of Science ®Google Scholar
• Jones, C. M., Einstein, E. B., & Compton, W. M. (2018, May 1). Changes in synthetic opioid involvement in drug overdose deaths in the United States, 2010-2016. JAMA, 319(17), 1819–1821. https://doi.org/10.1001/jama.2018.2844
   PubMed Web of Science ®Google Scholar
• Kariisa, M., Scholl, L., Wilson, N., Seth, P., & Hoots, B. (2019). Drug overdose deaths involving cocaine and psychostimulants with abuse potential - United States, 2003-2017. MMWR. Morbidity and Mortality Weekly Report, 68(17), 388–395. https://doi.org/10.15585/mmwr.mm6817a3
   PubMed Web of Science ®Google Scholar
• Kreek, M. J., Borg, L., Ducat, E., & Ray, B. (2010). Pharmacotherapy in the treatment of addiction: Methadone. Journal of Addictive Diseases, 29(2), 200–216. https://doi.org/10.1080/10550881003684798
   PubMed Web of Science ®Google Scholar
• Kroenke, K., Spitzer, R. L., Janet, B. W., Williams, D. S. W., Lö, B., Williams, J. B. W., & Lowe, B. (2009). An ultra-brief screening scale for anxiety and depression: The PHQ-4. Psychosomatics, 50(6), 613–621. https://doi.org/10.1016/S0033-3182(09)70864-3
   PubMed Web of Science ®Google Scholar
• Kurdyak, P., Gomes, T., Yao, Z., Mamdani, M. M., Hellings, C., Fischer, B., Rehm, J., Bayoumi, A. M., & Juurlink, D. N. (2012). Use of other opioids during methadone therapy: A population-based study. Addiction (Abingdon, England), 107(4), 776–780. https://doi.org/10.1111/j.1360-0443.2011.03707.x
   PubMed Web of Science ®Google Scholar
• Lanza, S. T., Collins, L. M., Lemmon, D. R., & Schafer, J. L. (2007). PROC LCA: A SAS procedure for latent class analysis. Structural Equation Modeling: A Multidisciplinary Journal, 14(4), 671–694. https://doi.org/10.1080/10705510701575602
   PubMed Web of Science ®Google Scholar
• Lanza, S. T., & Rhoades, B. L. (2013). Latent class analysis: An alternative perspective on subgroup analysis in prevention and treatment. Prevention Science : The Official Journal of the Society for Prevention Research, 14(2), 157–168. https://doi.org/10.1007/s11121-011-0201-1
   PubMed Web of Science ®Google Scholar
• Lanza, S. T., Dziak, J. J., Wagner, A., & Collins, L. M. (2015). PROC LCA & PROC LTA Users’ Guide. 1–54.
   Google Scholar
• Lanza, S. T., Rhoades, B. L., Nix, R. L., Greenberg, M. T., & Conduct Problems Prevention Research Group (2010). Modeling the interplay of multilevel risk factors for future academic and behavior problems: A person-centered approach. Development and Psychopathology, 22(2), 313–335. https://doi.org/10.1017/S0954579410000088
   PubMed Web of Science ®Google Scholar
• Lee, J. D., Nunes, E. V., Novo, P., Bachrach, K., Bailey, G. L., Bhatt, S., Farkas, S., Fishman, M., Gauthier, P., Hodgkins, C. C., King, J., Lindblad, R., Liu, D., Matthews, A. G., May, J., Peavy, K. M., Ross, S., Salazar, D., Schkolnik, P., … Rotrosen, J. (2018). Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): A multicentre, open-label, randomised controlled trial. The Lancet, 391(10118), 309–318. https://doi.org/10.1016/S0140-6736(17)32812-X
   PubMed Web of Science ®Google Scholar
• Levine, A. R., Lundahl, L. H., Ledgerwood, D. M., Lisieski, M., Rhodes, G. L., & Greenwald, M. K. (2015). Gender-specific predictors of retention and opioid abstinence during methadone maintenance treatment. Journal of Substance Abuse Treatment, 54, 37–43. https://doi.org/10.1016/j.jsat.2015.01.009
   PubMed Web of Science ®Google Scholar
• Li, L., Sangthong, R., Chongsuvivatwong, V., McNeil, E., & Li, J. (2011). Multiple substance use among heroin-dependent patients before and during attendance at methadone maintenance treatment program, Yunnan, China. Drug and Alcohol Dependence, 116(1-3), 246–249. https://doi.org/10.1016/j.drugalcdep.2010.12.007
   PubMed Web of Science ®Google Scholar
• Löwe, B., Wahl, I., Rose, M., Spitzer, C., Glaesmer, H., Wingenfeld, K., Schneider, A., & Brähler, E. (2010). A 4-item measure of depression and anxiety: Validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. Journal of Affective Disorders, 122(1-2), 86–95. https://doi.org/10.1016/j.jad.2009.06.019
   PubMed Web of Science ®Google Scholar
• Magura, S., & Rosenblum, A. (2001). Leaving methadone treatment: Lessons learned, lessons forgotten, lessons ignored. The Mount Sinai Journal of Medicine, New York, 68(1), 62–74. Retrieved from http://europepmc.org/abstract/MED/11135508
   PubMed Web of Science ®Google Scholar
• Maremmani, I., Pani, P. P., Mellini, A., Pacini, M., Marini, G., Lovrecic, M., Perugi, G., & Shinderman, M. (2007). Alcohol and cocaine use and abuse among opioid addicts engaged in a methadone maintenance treatment program. Journal of Addictive Diseases, 26(1), 61–70. https://doi.org/10.1300/J069v26n01_08
   PubMed Web of Science ®Google Scholar
• Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2014). Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews, CD002207 (2), 1–85. https://doi.org/10.1002/14651858.CD002207.pub4
   Web of Science ®Google Scholar
• McCabe, S. E., West, B. T., Jutkiewicz, E. M., & Boyd, C. J. (2017). Multiple DSM ‐ 5 substance use disorders: A national study of US adults. Human Psychopharmacology: Clinical and Experimental, 32(5), e2625. https://doi.org/10.1002/hup.2625
   Web of Science ®Google Scholar
• McHugh, R. K., Devito, E. E., Dodd, D., Carroll, K. M., Potter, J. S., Greenfield, S. F., Connery, H. S., & Weiss, R. D. (2013). Gender differences in a clinical trial for prescription opioid dependence. Journal of Substance Abuse Treatment, 45(1), 38–43. https://doi.org/10.1016/j.jsat.2012.12.007
   PubMed Web of Science ®Google Scholar
• Midanik, L. T., Tam, T. W., & Weisner, C. (2007). Concurrent and simultaneous drug and alcohol use: Results of the 2000 National Alcohol Survey. Drug and Alcohol Dependence, 90(1), 72–80. https://doi.org/10.1016/j.drugalcdep.2007.02.024
   PubMed Web of Science ®Google Scholar
• Morley, K. I., Ferris, J. A., Winstock, A. R., & Lynskey, M. T. (2017). Polysubstance use and misuse or abuse of prescription opioid analgesics: a multi-level analysis of international data. Pain, 158(6), 1138–1144. https://doi.org/10.1097/j.pain.0000000000000892
   PubMed Web of Science ®Google Scholar
• Nicolai, J., Moshagen, M., & Demmel, R. (2012). Patterns of alcohol expectancies and alcohol use across age and gender. Drug and Alcohol Dependence, 126(3), 347–353. https://doi.org/10.1016/j.drugalcdep.2012.05.040
   PubMed Web of Science ®Google Scholar
• Nielsen, S., Larance, B., & Lintzeris, N. (2017). Opioid agonist treatment for patients with dependence on prescription opioids. JAMA, 317(9), 967–968. https://doi.org/10.1001/jama.2017.0001
   PubMed Web of Science ®Google Scholar
• Nosyk, B., Fischer, B., Sun, H., Marsh, D. C., Kerr, T., Rehm, J. T., & Anis, A.H. (2014). High levels of opioid analgesic co-prescription among methadone maintenance treatment clients in British Columbia, Canada: Results from a population-level retrospective cohort study. The American Journal on Addictions, 23(3), 257–264. https://doi.org/10.1111/j.1521-0391.2014.12091.x
   PubMed Web of Science ®Google Scholar
• Nosyk, B., MacNab, Y. C., Sun, H., Fischer, B., Marsh, D. C., Schechter, M. T., & Anis, A. H. (2009). Proportional hazards frailty models for recurrent methadone maintenance treatment. American Journal of Epidemiology, 170(6), 783–792. https://doi.org/10.1093/aje/kwp186
   PubMed Web of Science ®Google Scholar
• Nosyk, B., Sun, H., Evans, E., Marsh, D. C., Anglin, M. D., Hser, Y.-I., & Anis, A.H. (2012). Defining dosing pattern characteristics of successful tapers following methadone maintenance treatment: Results from a population-based retrospective cohort study. Addiction (Addiction), 107(9), 1621–1629. https://doi.org/10.1111/j.1360-0443.2012.03870.x
   PubMed Web of Science ®Google Scholar
• Olière, S., Joliette-Riopel, A., Potvin, S., & Jutras-Aswad, D. (2013). Modulation of the endocannabinoid system: Vulnerability factor and new treatment target for stimulant addiction. Frontiers in Psychiatry, 4, 109. https://doi.org/10.3389/fpsyt.2013.00109
   PubMedGoogle Scholar
• Polenick, C. A., Cotton, B. P., Bryson, W. C., & Birditt, K. S. (2019). Loneliness and illicit opioid use among methadone maintenance treatment patients. Substance Use & Misuse, 54 (13), 1–10. https://doi.org/10.1080/10826084.2019.1628276
   PubMed Web of Science ®Google Scholar
• Proctor, S. L., Copeland, A. L., Kopak, A. M., Hoffmann, N. G., Herschman, P.L., & Polukhina, N. (2015). Predictors of patient retention in methadone maintenance treatment. Psychol Addict Behav, 29(4), 906–917. https://doi.org/10.1037/adb0000090
   PubMed Web of Science ®Google Scholar
• Rosic, T., Naji, L., Bawor, M., Dennis, B., Plater, C., Marsh, D., Thabane, L., & Samaan, Z. (2017). The impact of comorbid psychiatric disorders on methadone maintenance treatment in opioid use disorder: A prospective cohort study. Neuropsychiatric Disease and Treatment, 13, 1399–1408. https://doi.org/10.2147/NDT.S129480
   PubMed Web of Science ®Google Scholar
• Roux, P., Lions, C., Vilotitch, A., Michel, L., Mora, M., Maradan, G., Marcellin, F., Spire, B., Morel, A., Carrieri, P. M., & ANRS Methaville study group (2016). Correlates of cocaine use during methadone treatment: Implications for screening and clinical management (ANRS Methaville study). Harm Reduction Journal, 13(1), 12. https://doi.org/10.1186/s12954-016-0100-7
   PubMedGoogle Scholar
• Scholl, L., Seth, P., Kariisa, M., Wilson, N., & Baldwin, G. (2018). Drug and opioid-involved overdose deaths — United States, 2013–2017. MMWR. Morbidity and Mortality Weekly Report, 67(5152), 1419–1427. https://doi.org/10.15585/mmwr.mm675152e1
   Google Scholar
• Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., Hergueta, T., Baker, R., & Dunbar, G.C. (1998). The mini-international neuropsychiatric interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-1V and ICD-10. Journal of Clinical Psychiatry, 59(S20), 22–33.
   PubMedGoogle Scholar
• Soyka, M. (2017). Treatment of opioid dependence with buprenorphine: Current update. Dialogues in Clinical Neuroscience, 19(3), 299–308.
   PubMed Web of Science ®Google Scholar
• Stenbacka, M., Beck, O., Leifman, A., Romelsjö, A., & Helander, A. (2007). Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment. Drug and Alcohol Review, 26(1), 55–63. https://doi.org/10.1080/09595230601036994
   PubMed Web of Science ®Google Scholar
• Subbaraman, M. S., & Kerr, W. C. (2015). Simultaneous versus concurrent use of alcohol and cannabis in the. National Alcohol Survey. Alcoholism: Clinical and Experimental Research, 39(5), 872–879.
   PubMed Web of Science ®Google Scholar
• Tetrault, J. M., Desai, R. A., Becker, W. C., Fiellin, D. A., Concato, J., & Sullivan, L.E. (2008). Gender and non-medical use of prescription opioids: results from a national US survey*. Addiction, 103(2), 258–268. https://doi.org/10.1111/j.1360-0443.2007.02056.x
   PubMed Web of Science ®Google Scholar
• Timko, C., Han, X., Woodhead, E., Shelley, A., & Cucciare, M.A. (2018). Polysubstance use by stimulant users: Health outcomes over three years. Journal of Studies on Alcohol and Drugs, 79(5), 799–807.
   PubMed Web of Science ®Google Scholar
• Vigna-Taglianti, F. D., Burroni, P., Mathis, F., Versino, E., Beccaria, F., Rotelli, M., Garneri, M., Picciolini, A., Bargagli, A. M., & VEdeTTE Study Group (2016). Gender differences in heroin addiction and treatment: Results from the VEdeTTE cohort. Substance Use & Misuse, 51(3), 295–309. https://doi.org/10.3109/10826084.2015.1108339
   PubMed Web of Science ®Google Scholar
• Ward, J., Mattick, R., & Hall, W. (1994). The effectiveness of methadone maintenance treatment: An overview. Drug and Alcohol Review, 13(3), 327–335. https://doi.org/10.1080/09595239400185431
   PubMedGoogle Scholar
• White, W. L., Campbell, M. D., Spencer, R. D., Hoffman, H. A., Crissman, B., & Dupont, R. L. (2014). Patterns of abstinence or continued drug use among methadone maintenance patients and their relation to treatment retention. Journal of Psychoactive Drugs, 46(2), 114–122. https://doi.org/10.1080/02791072.2014.901587 25052787
   PubMed Web of Science ®Google Scholar
• Winetrobe, H., Wenzel, S., Rhoades, H., Henwood, B., Rice, E., & Harris, T. (2017). Differences in health and social support between homeless men and women entering permanent supportive housing. Women’s Health Issues, 27(3), 286–293. https://doi.org/10.1016/j.whi.2016.12.011
   PubMed Web of Science ®Google Scholar
• Zambon, A., Airoldi, C., Corrao, G., Cibin, M., Agostini, D., Aliotta, F., Movalli, M., Biondini, F., Bizzi, P., Zucchi, G., Cerizza, G., Dattola, A., Marmora, A., Vittadini, G., Girardi, F., Liberto, L., Hinnenthal, I.M., Sodano, A.J., Vizzuso, P., … Giorgi, I. (2017). Prevalence of polysubstance abuse and dual diagnosis in patients admitted to alcohol rehabilitation units for alcohol-related problems in Italy: Changes in 15 years. Alcohol and Alcoholism, 52(6), 699–705. https://doi.org/10.1093/alcalc/agx061
   PubMed Web of Science ®Google Scholar